|
JP2884452B2
(ja)
|
1991-10-09 |
1999-04-19 |
清水建設株式会社 |
セグメントを利用した立坑構築工法
|
|
WO2007079139A2
(en)
|
2005-12-28 |
2007-07-12 |
Vertex Pharmaceuticals, Inc. |
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
MX2010007419A
(es)
|
2008-01-04 |
2010-11-12 |
Intellikine Inc |
Ciertas entidades quimicas, composiciones y metodos.
|
|
CN102202677A
(zh)
|
2008-09-03 |
2011-09-28 |
阿尔伯维塔公司 |
治疗疼痛的活性剂和方法
|
|
CA2781888C
(en)
|
2009-12-11 |
2019-06-18 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
|
CA2799579A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
AU2011202542A1
(en)
*
|
2010-07-14 |
2012-02-02 |
Indian Institute Of Science |
Benzothiophene carboxamide compounds, composition and applications thereof
|
|
SG187103A1
(en)
|
2010-07-16 |
2013-02-28 |
Abbvie Inc |
Phosphine ligands for catalytic reactions
|
|
US9255074B2
(en)
|
2010-07-16 |
2016-02-09 |
Abbvie Inc. |
Process for preparing antiviral compounds
|
|
CA2805748A1
(en)
|
2010-07-16 |
2012-01-19 |
Shashank Shekhar |
Process for preparing n-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1-(2h)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide
|
|
US8975443B2
(en)
|
2010-07-16 |
2015-03-10 |
Abbvie Inc. |
Phosphine ligands for catalytic reactions
|
|
CN103201279A
(zh)
|
2010-11-05 |
2013-07-10 |
赛诺米克斯公司 |
作为trpm8的调节剂有用的化合物
|
|
JP5951625B2
(ja)
|
2010-11-24 |
2016-07-13 |
ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨークＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｃｏｌｕｍｂｉａ Ｕｎｉｖｅｒｓｉｔｙ Ｉｎ Ｔｈｅ Ｃｉｔｙ Ｏｆ Ｎｅｗ Ｙｏｒｋ |
加齢性黄斑変性症およびシュタルガルト病の処置のための非レチノイドｒｂｐ４アンタゴニスト
|
|
ES2637113T3
(es)
|
2011-01-10 |
2017-10-10 |
Infinity Pharmaceuticals, Inc. |
Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
|
|
US9334256B2
(en)
|
2011-06-15 |
2016-05-10 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
|
AR088218A1
(es)
|
2011-07-19 |
2014-05-21 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos utiles como inhibidores de pi3k
|
|
KR20130016041A
(ko)
*
|
2011-08-04 |
2013-02-14 |
재단법인 의약바이오컨버젼스연구단 |
신규한 아닐린 유도체 및 이의 용도
|
|
MX2014002542A
(es)
|
2011-08-29 |
2014-07-09 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos.
|
|
CN104220053B
(zh)
|
2012-02-10 |
2017-05-03 |
德克萨斯大学系统董事会 |
cAMP直接活化交换蛋白(EPAC)的调节剂
|
|
EP2831071B1
(en)
*
|
2012-03-29 |
2018-11-14 |
Merck Sharp & Dohme Corp. |
Imidazolyl methyl piperidine t-type calcium channel antagonists
|
|
US9333202B2
(en)
|
2012-05-01 |
2016-05-10 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
CN103570705B
(zh)
*
|
2012-07-18 |
2017-01-25 |
中国医学科学院医药生物技术研究所 |
取代的n‑((1＇,3＇‑杂唑‑4＇‑基)‑甲基)‑4‑苯甲酰基六氢吡啶类化合物及其用途
|
|
ES2660210T3
(es)
|
2012-09-07 |
2018-03-21 |
Novartis Ag |
Derivados de indolcarboxamida y usos de los mismos
|
|
BR102012024778A2
(pt)
*
|
2012-09-28 |
2014-08-19 |
Cristalia Prod Quimicos Farm |
Compostos heteroaromáticos; processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica
|
|
AU2013337717B2
(en)
|
2012-11-01 |
2018-10-25 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using PI3 kinase isoform modulators
|
|
EP2733146A1
(en)
*
|
2012-11-20 |
2014-05-21 |
KTB Tumorforschungsgesellschaft mbH |
Thioether derivatives as protein kinase inhibitors
|
|
JP6218848B2
(ja)
*
|
2012-11-20 |
2017-10-25 |
プロキナーゼ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
プロテインキナーゼ阻害剤としてのチオエーテル誘導体
|
|
CA2899124A1
(en)
|
2013-01-25 |
2014-07-31 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds
|
|
TWI644899B
(zh)
|
2013-02-04 |
2018-12-21 |
健生藥品公司 |
Ｆｌａｐ調節劑
|
|
US9079866B2
(en)
|
2013-02-04 |
2015-07-14 |
Janssen Pharmaceutica Nv |
Flap modulators
|
|
EP3495357B1
(en)
|
2013-03-14 |
2021-05-05 |
The Trustees of Columbia University in the City of New York |
4-phenylpiperidines, their preparation and use
|
|
US9938291B2
(en)
|
2013-03-14 |
2018-04-10 |
The Trustess Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
|
WO2014152018A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
WO2015039333A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
CN105829297B
(zh)
*
|
2013-12-20 |
2019-08-09 |
埃斯蒂文制药股份有限公司 |
具有抗疼痛的多重模式活性的哌啶化合物
|
|
EP3705570A1
(en)
|
2014-02-10 |
2020-09-09 |
Institut Curie |
Use of mcoln-1 modulators to regulate cell migration
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
SG11201608943VA
(en)
|
2014-04-30 |
2016-11-29 |
Univ Columbia |
Substituted 4-phenylpiperidines, their preparaiton and use
|
|
US20170273922A1
(en)
*
|
2014-10-03 |
2017-09-28 |
The Royal Institution For The Advacement Of Learning/Mcgill University |
Urea and bis-urea based compounds and analogues thereof useful in the treatment of androgen receptor mediated diseases or disorders
|
|
KR20170063954A
(ko)
|
2014-10-07 |
2017-06-08 |
버텍스 파마슈티칼스 인코포레이티드 |
낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정
|
|
KR102490156B1
(ko)
|
2014-10-24 |
2023-01-18 |
다케다 야쿠힌 고교 가부시키가이샤 |
헤테로시클릭 화합물
|
|
WO2016077793A1
(en)
*
|
2014-11-14 |
2016-05-19 |
Children's Hospital Medical Center |
Sos1 inhibitors for cancer treatment
|
|
US9670205B2
(en)
|
2015-03-04 |
2017-06-06 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
US9737512B2
(en)
|
2015-03-11 |
2017-08-22 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for treating chronic pain
|
|
WO2017007756A1
(en)
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc |
Hetero-halo inhibitors of histone deacetylase
|
|
EP3319968A1
(en)
|
2015-07-06 |
2018-05-16 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
|
CN108473484B
(zh)
|
2015-10-01 |
2021-06-29 |
弗门尼舍公司 |
可用作trpm8调节剂的化合物
|
|
WO2017097182A1
(zh)
*
|
2015-12-07 |
2017-06-15 |
成都海创药业有限公司 |
喹啉类化合物及其制备方法和作为尿酸盐转运体抑制剂类药物的用途
|
|
SG11201811237WA
(en)
|
2016-06-24 |
2019-01-30 |
Infinity Pharmaceuticals Inc |
Combination therapies
|
|
AU2017318601B2
(en)
|
2016-09-02 |
2020-09-03 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
CN106565643A
(zh)
*
|
2016-10-31 |
2017-04-19 |
北京大学 |
D‑3‑磷酸甘油酸脱氢酶别构抑制剂及其应用
|
|
US10722489B2
(en)
*
|
2016-10-31 |
2020-07-28 |
Peking University |
D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof
|
|
HUE057849T2
(hu)
|
2017-01-11 |
2022-06-28 |
Alkermes Inc |
Hiszton deacetiláz biciklusos gátlói
|
|
CN106822897B
(zh)
*
|
2017-02-17 |
2018-10-19 |
河北盛华尔生物医疗科技有限公司 |
靶向下调trpm7基因表达在提高肺鳞癌化疗敏感性方面的应用
|
|
CN120136858A
(zh)
*
|
2017-03-31 |
2025-06-13 |
中美博瑞纳制药有限公司 |
可用作alcat1抑制剂的化合物
|
|
WO2018232160A1
(en)
*
|
2017-06-15 |
2018-12-20 |
Belite Bio, Inc |
Methods of treating metabolic diseases with phenoxyethylamides
|
|
US11389444B2
(en)
|
2017-06-15 |
2022-07-19 |
Belite Bio, Inc |
Methods of treating metabolic diseases with fused bicyclic pyrazoles
|
|
US10245259B2
(en)
|
2017-06-15 |
2019-04-02 |
Belite Bio, Inc |
Methods of treating RBP4 related diseases with triazolopyridines
|
|
LT3664802T
(lt)
|
2017-08-07 |
2022-06-27 |
Alkermes, Inc. |
Bicikliniai histonų deacetilazės inhibitoriai
|
|
PY19106549A
(es)
*
|
2018-12-21 |
2021-07-13 |
Bayer Ag |
1,3,4-oxadiazoles y derivados de éstos como nuevos agentes fungicidas
|
|
TWI751516B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI879779B
(zh)
|
2019-06-28 |
2025-04-11 |
美商基利科學股份有限公司 |
類鐸受體調節劑化合物的製備方法
|
|
AU2020310120B2
(en)
|
2019-07-08 |
2025-05-29 |
Belite Bio (HK) Limited |
Formulations of RBP4 inhibitors and methods of use
|
|
CN115210229A
(zh)
|
2020-01-03 |
2022-10-18 |
博格有限责任公司 |
多环酰胺作为治疗癌症的ube2k调节剂
|
|
WO2021257863A1
(en)
|
2020-06-19 |
2021-12-23 |
Incyte Corporation |
Pyrrolotriazine compounds as jak2 v617f inhibitors
|
|
US11691971B2
(en)
|
2020-06-19 |
2023-07-04 |
Incyte Corporation |
Naphthyridinone compounds as JAK2 V617F inhibitors
|
|
CR20230057A
(es)
|
2020-07-02 |
2023-08-15 |
Incyte Corp |
Compuestos tríciclicos de urea como inhibidores de jak2 v617f
|
|
US11767323B2
(en)
|
2020-07-02 |
2023-09-26 |
Incyte Corporation |
Tricyclic pyridone compounds as JAK2 V617F inhibitors
|
|
US11661422B2
(en)
|
2020-08-27 |
2023-05-30 |
Incyte Corporation |
Tricyclic urea compounds as JAK2 V617F inhibitors
|
|
WO2022119823A1
(en)
*
|
2020-12-04 |
2022-06-09 |
The Johns Hopkins University |
Compounds and their use for treating neuropathic pain
|
|
US11919908B2
(en)
|
2020-12-21 |
2024-03-05 |
Incyte Corporation |
Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
|
|
WO2022148781A1
(en)
|
2021-01-05 |
2022-07-14 |
Institut Curie |
Combination of mcoln activators and immune checkpoint inhibitors
|
|
AR125273A1
(es)
|
2021-02-25 |
2023-07-05 |
Incyte Corp |
Lactamas espirocíclicas como inhibidores de jak2 v617f
|
|
KR102905373B1
(ko)
*
|
2021-04-08 |
2025-12-29 |
주식회사 종근당 |
히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 싸이오카보닐 화합물 및 이를 포함하는 약제학적 조성물
|
|
CN114685371A
(zh)
*
|
2022-03-08 |
2022-07-01 |
四川大学 |
吡唑甲酰胺衍生物及其制备方法和用途
|
|
AU2023235313A1
(en)
|
2022-03-17 |
2024-10-03 |
Incyte Corporation |
Tricyclic urea compounds as jak2 v617f inhibitors
|
|
US20260085073A1
(en)
*
|
2022-09-12 |
2026-03-26 |
Hotspot Therapeutics, Inc. |
Pyrazolylcarboxamide compounds and their use in therapy
|